Titel-Story der GIE Juni-Ausgabe: invendo medical's Pilotstudie

KISSING, GERMANY, June 11, 2008 – invendo medical, developer of the breakthrough single-use invendoscope™ SC20 which will potentially allow for sedation- and painless colonoscopy, announced that a paper by Prof. Thomas Roesch, M.D., of Charité University Hospitals Berlin (Germany), about a pilot study using the invendoscope™ has been published in Gastrointestinal Endoscopy (GIE). GIE is ASGE's (American Society for Gastrointestinal Endoscopy) monthly, peer-reviewed scientific journal and the leading international publication in the field of gastrointestinal endoscopy.


The study has shown the absence of pain in 92% of the cases, although no sedation has been used. The GIE article can be accessed here.

About the single-use invendoscope™ SC20

invendo’s patented device combines a highly flexible endoscope shaft and proprietary ‘inverted sleeve’ technology that potentially enables a painless colonoscopy, as there are no direct forces applied against the intestinal wall while the device passes through narrow intestinal convolutions, thus enabling a safe and potentially painless examination of the large intestine. invendo’s colonoscope is CE-marked in Europe. Market launch is expected in 2009.

About invendo medical GmbH

Headquartered in Kissing (Munich), Germany, invendo medical (www.invendo-medical.com) is a leading developer of novel disposable endoscopy products in the field of gastroenterology that are simple to use and potentially reduce pain compared to conventional modalities.

Contact:
Timo Hercegfi, CFO
invendo medical GmbH
+49 8233 74498 0
timo.hercegfi@invendo-medical.de

« Zurück